Aemetis (NASDAQ:AMTX) Releases Earnings Results, Beats Estimates By $0.09 EPS

Aemetis (NASDAQ:AMTX) posted its quarterly earnings data on Tuesday. The specialty chemicals company reported ($0.38) earnings per share for the quarter, beating the consensus estimate of ($0.47) by $0.09, Zacks reports. The business had revenue of $81.44 million during the quarter, compared to the consensus estimate of $77.79 million. During the same period in the prior year, the company posted ($0.59) earnings per share.

Aemetis Stock Performance

Shares of NASDAQ AMTX traded down $0.06 during trading on Thursday, reaching $4.07. The company had a trading volume of 848,065 shares, compared to its average volume of 807,098. Aemetis has a 52 week low of $2.10 and a 52 week high of $7.03. The business’s 50 day moving average price is $2.77 and its 200-day moving average price is $3.06. The stock has a market cap of $192.09 million, a PE ratio of -1.80 and a beta of 1.23.

Analyst Ratings Changes

Several research firms have issued reports on AMTX. StockNews.com upgraded shares of Aemetis to a “sell” rating in a research report on Wednesday, July 31st. Ascendiant Capital Markets cut their price target on Aemetis from $20.00 to $19.00 and set a “buy” rating for the company in a report on Tuesday, September 3rd. HC Wainwright restated a “buy” rating and set a $28.00 price objective on shares of Aemetis in a research report on Friday, August 2nd. UBS Group reduced their target price on Aemetis from $8.25 to $7.75 and set a “buy” rating for the company in a research report on Monday, August 19th. Finally, Truist Financial reissued a “hold” rating and issued a $3.50 price target (down previously from $4.00) on shares of Aemetis in a report on Wednesday, July 31st. One analyst has rated the stock with a sell rating, one has given a hold rating and four have issued a buy rating to the company. According to data from MarketBeat.com, Aemetis currently has a consensus rating of “Moderate Buy” and an average target price of $12.95.

About Aemetis

Aemetis, Inc operates as a renewable natural gas and renewable fuels company. It operates through three segments: California Ethanol, California Dairy Renewable Natural Gas, and India Biodiesel. The company focuses on the operation, acquisition, development, and commercialization of technologies to produce low and negative carbon intensity renewable fuels that replace fossil-based products.